SCHEMBL19264778

SCHEMBL19264778

Cc1c[nH]c(C(=O)Nc2ccc([C@@]3(O)C[C@@]4(C)O[C@@](C)(C3)[C@H](C)[C@@H]4O)cc2C2=CCC(C)(C)CC2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13877912 0.96 — —
SCHEMBL13877911 0.90 — —
SCHEMBL14374730 0.88 — —
SCHEMBL13877909 0.88 — —
SCHEMBL13877928 0.86 — —
SCHEMBL13877987 0.86 — —
SCHEMBL4236246 0.86 — —
SCHEMBL14383682 0.85 — —
SCHEMBL14374725 0.85 — —
SCHEMBL13877929 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3208269-B1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2021-09-15 — — EP disclosed
EP-3208269-A1 INHIBITORS OF C-FMS KINASE Janssen Pharmaceutica N.V. (BE) 2017-08-23 — — EP disclosed
Send feedback